Skip to content
Screener

Orthofix Medical Inc. OFIX Cash & Equivalents

Cash & Equivalents at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$20.42B+9.9%
Stryker logo
StrykerSYK
$3.39B+42.8%
Globus Medical logo
Globus MedicalGMED
$507.75M+121%
Alphatec Holdings logo
Alphatec HoldingsATEC
$139.91M-8.7%
Enovis logo
EnovisENOV
$12.56M-71.5%
OrthoPediatrics logo
OrthoPediatricsKIDS
$19.06M-59.1%

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$417.92M-18.2%
Enterprise value$551.79M-11.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(U.S. Dollars, in thousands, except par value data)June 30,2026December 31,2025
(Unaudited)
Assets
Current assets
Cash and cash equivalents$103,810$82,025
Restricted cash5953,090
Accounts receivable, net of allowances of $10,563 and $8,308, respectively135,818135,746
Inventories184,475172,319
Prepaid expenses and other current assets21,43423,667

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s cash & equivalents?
Orthofix Medical Inc. (OFIX) reported cash & equivalents of $103.81M in Q2 2026.
How has Orthofix Medical Inc.'s cash & equivalents changed year-over-year?
Orthofix Medical Inc.'s cash & equivalents increased by 58.2% year-over-year, from $65.61M to $103.81M.
What is the long-term trend for Orthofix Medical Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Orthofix Medical Inc.'s cash & equivalents has grown at a -3.2% compound annual growth rate (CAGR), from $96.29M to $82.03M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Orthofix Medical Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude